BRISTOL-MYERS SQUIBB CO (BMY) Stock Fundamental Analysis

NYSE:BMY • US1101221083

61.205 USD
-0.4 (-0.64%)
Last: Feb 25, 2026, 11:00 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BMY. BMY was compared to 192 industry peers in the Pharmaceuticals industry. While BMY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BMY is cheap, but on the other hand it scores bad on growth. Finally BMY also has an excellent dividend rating. This makes BMY very considerable for value and dividend investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • BMY had positive earnings in the past year.
  • In the past year BMY had a positive cash flow from operations.
  • BMY had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BMY had a positive operating cash flow.
BMY Yearly Net Income VS EBIT VS OCF VS FCFBMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B

1.2 Ratios

  • The Return On Assets of BMY (7.83%) is better than 89.06% of its industry peers.
  • BMY's Return On Equity of 38.19% is amongst the best of the industry. BMY outperforms 96.88% of its industry peers.
  • With an excellent Return On Invested Capital value of 19.52%, BMY belongs to the best of the industry, outperforming 96.35% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BMY is in line with the industry average of 12.96%.
  • The 3 year average ROIC (14.47%) for BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROIC 19.52%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
BMY Yearly ROA, ROE, ROICBMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With an excellent Profit Margin value of 14.64%, BMY belongs to the best of the industry, outperforming 86.46% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BMY has grown nicely.
  • BMY has a better Operating Margin (35.82%) than 95.83% of its industry peers.
  • BMY's Operating Margin has improved in the last couple of years.
  • BMY's Gross Margin of 72.63% is amongst the best of the industry. BMY outperforms 80.73% of its industry peers.
  • BMY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
BMY Yearly Profit, Operating, Gross MarginsBMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BMY is creating value.
  • Compared to 1 year ago, BMY has more shares outstanding
  • BMY has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BMY has been reduced compared to a year ago.
BMY Yearly Shares OutstandingBMY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BMY Yearly Total Debt VS Total AssetsBMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • BMY has an Altman-Z score of 2.56. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BMY's Altman-Z score of 2.56 is fine compared to the rest of the industry. BMY outperforms 66.67% of its industry peers.
  • The Debt to FCF ratio of BMY is 3.51, which is a good value as it means it would take BMY, 3.51 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 3.51, BMY belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that BMY has dependencies on debt financing.
  • BMY has a Debt to Equity ratio of 2.33. This is in the lower half of the industry: BMY underperforms 78.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Altman-Z 2.56
ROIC/WACC2.25
WACC8.68%
BMY Yearly LT Debt VS Equity VS FCFBMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • BMY has a Current Ratio of 1.26. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • BMY has a worse Current ratio (1.26) than 77.08% of its industry peers.
  • BMY has a Quick Ratio of 1.14. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
  • BMY has a worse Quick ratio (1.14) than 74.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.14
BMY Yearly Current Assets VS Current LiabilitesBMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 439.47% over the past year.
  • Measured over the past years, BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
  • The Revenue has decreased by -0.22% in the past year.
  • Measured over the past years, BMY shows a small growth in Revenue. The Revenue has been growing by 2.54% on average per year.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%

3.2 Future

  • Based on estimates for the next years, BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.54% on average per year.
  • The Revenue is expected to decrease by -5.62% on average over the next years.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BMY Yearly Revenue VS EstimatesBMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
BMY Yearly EPS VS EstimatesBMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.95, the valuation of BMY can be described as very reasonable.
  • Based on the Price/Earnings ratio, BMY is valued cheaper than 92.71% of the companies in the same industry.
  • BMY is valuated cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • BMY is valuated reasonably with a Price/Forward Earnings ratio of 10.06.
  • Based on the Price/Forward Earnings ratio, BMY is valued cheaper than 88.54% of the companies in the same industry.
  • BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.95
Fwd PE 10.06
BMY Price Earnings VS Forward Price EarningsBMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaper than 93.23% of the companies in the same industry.
  • 91.67% of the companies in the same industry are more expensive than BMY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.7
EV/EBITDA 7.48
BMY Per share dataBMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The excellent profitability rating of BMY may justify a higher PE ratio.
  • A cheap valuation may be justified as BMY's earnings are expected to decrease with -3.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • BMY has a Yearly Dividend Yield of 4.18%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.07, BMY pays a better dividend. On top of this BMY pays more dividend than 96.88% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, BMY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

  • The dividend of BMY is nicely growing with an annual growth rate of 6.51%!
  • BMY has paid a dividend for at least 10 years, which is a reliable track record.
  • BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years3
Div Non Decr Years3
BMY Yearly Dividends per shareBMY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 71.52% of the earnings are spent on dividend by BMY. This is not a sustainable payout ratio.
  • The Dividend Rate of BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
BMY Yearly Income VS Free CF VS DividendBMY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B 15B
BMY Dividend Payout.BMY Dividend Payout, showing the Payout Ratio.BMY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (2/25/2026, 11:00:06 AM)

61.205

-0.4 (-0.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners81.87%
Inst Owner Change0.41%
Ins Owners0.02%
Ins Owner Change-1.12%
Market Cap124.60B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.59
Price Target58.05 (-5.15%)
Short Float %1.47%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)2.01%
PT rev (3m)9.49%
EPS NQ rev (1m)1.98%
EPS NQ rev (3m)-3.3%
EPS NY rev (1m)0.24%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)3.43%
Revenue NQ rev (3m)3.33%
Revenue NY rev (1m)6.84%
Revenue NY rev (3m)7.45%
Valuation
Industry RankSector Rank
PE 9.95
Fwd PE 10.06
P/S 2.59
P/FCF 9.7
P/OCF 8.8
P/B 6.74
P/tB N/A
EV/EBITDA 7.48
EPS(TTM)6.15
EY10.05%
EPS(NY)6.09
Fwd EY9.94%
FCF(TTM)6.31
FCFY10.31%
OCF(TTM)6.95
OCFY11.36%
SpS23.67
BVpS9.07
TBVpS-11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.44
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 38.19%
ROCE 25.91%
ROIC 19.52%
ROICexc 23.22%
ROICexgc 84.94%
OM 35.82%
PM (TTM) 14.64%
GM 72.63%
FCFM 26.65%
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 3.51
Debt/EBITDA 2.03
Cap/Depr 32.69%
Cap/Sales 2.72%
Interest Coverage 8.22
Cash Conversion 66.54%
Profit Quality 182.1%
Current Ratio 1.26
Quick Ratio 1.14
Altman-Z 2.56
F-Score7
WACC8.68%
ROIC/WACC2.25
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year13.96%
EBIT Next 3Y0.03%
EBIT Next 5Y-1.73%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%

BRISTOL-MYERS SQUIBB CO / BMY FAQ

What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BMY.


What is the valuation status for BMY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.


What is the profitability of BMY stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 9 / 10.


Can you provide the financial health for BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.


What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?

The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to decline by -1.05% in the next year.